Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford University has received a landmark £80 million donation from the Reuben Foundation that will transform Oxford’s newest college and establish a major new scholarship programme for graduate and undergraduate students.

Reuben College located in Oxford © Alison Stibbe

The University last year established its 39th college – the first for 30 years – as a new base for graduate students who are eager to embrace opportunities for interdisciplinary exchange and apply their research to address key future challenges. Initially named Parks College for its location on Parks Road, the college is now set to become ‘Reuben College’, in recognition of the historic gift that secures its vision of a diverse, dynamic research community working on some of the key issues of our time.

Due to welcome its first students in the autumn of 2021, Reuben College has already attracted an outstanding line-up of academic Fellows. The college aims to generate new insights into the biggest questions of our time by bringing academics from traditionally different disciplines together to work on challenging themes and share their knowledge with the college’s graduate students. A culture of innovation and enterprise and a strong commitment to diversity, sustainability and public engagement will cut across all interdisciplinary activities. The college’s initial research themes are: Artificial Intelligence and Machine Learning; Environmental Change; and Cellular Life, which includes ongoing work in understanding COVID-19 and the current pandemic.

Read more on the University of Oxford website

Similar stories

Human challenge trial launches to study immune response to COVID-19

Clinical Trials Coronavirus COVID-19 General

Though the COVID-19 pandemic has now been active for a year, not much is known about what happens when people who have already had COVID-19 are infected for a second time.

Alternating vaccines trial expands to include two additional vaccines

Clinical Trials Coronavirus COVID-19 General

Researchers running the Com-Cov study, launched in February to investigate alternating doses of the Oxford-AstraZeneca vaccine and the Pfizer vaccine, have today announced that the programme will be extended to include the Moderna and Novavax vaccines in a new study.

Oxford medical students launch flagship raffle in aid of NHS heroes and lifesaving medical equipment

General

Tingewick, a society formed of medical students from Oxford University, are hosting a virtual charity raffle. With over 70 amazing prizes, ranging from Truck festival tickets to restaurant vouchers to bags of books and even a bike, the raffle is an exciting way to celebrate lockdown lifting by supporting many wonderful Oxfordshire businesses whilst raising lots of money for charity.

UK and EU regulators conclude benefits of vaccination continue to outweigh the risks

Coronavirus COVID-19 General

Today, the medical regulators in the UK and Europe have announced their conclusions from their reviews of very rare cases of unusual blood clots in people who have received the Oxford-AstraZeneca coronavirus vaccine.

Link between COVID-19 infection and subsequent mental health and neurological conditions found

Coronavirus COVID-19 General Research

One in three COVID-19 survivors received a neurological or psychiatric diagnosis within six months of infection with the SARS-CoV-2 virus, an observational study of more than 230,000 patient health records published in The Lancet Psychiatry journal estimates. The study looked at 14 neurological and mental health disorders.